Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
about
Development of Cardiovascular Indices of Acute Pain Responding in Infants: A Systematic ReviewA patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial.Prenatal antidepressant exposure: clinical and preclinical findings.Fetal effects of psychoactive drugsThe mothers, Omega-3 and mental health study.Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.Transcranial direct current stimulation (tDCS) for treatment of major depression during pregnancy: study protocol for a pilot randomized controlled trialDevelopmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring.The safety of antidepressant drugs during pregnancy.Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatmentThe relationship between women's attachment style and perinatal mood disturbance: implications for screening and treatment.Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feedingUterine blood flow in a psychiatric population: impact of maternal depression, anxiety, and psychotropic medicationSertraline exposure leads to small left heart syndrome in adult mice.Prenatal alcohol exposure alters biobehavioral reactivity to pain in newborns.The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspringOf rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptationSustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidenceInvestigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.Physiological measures of assessing infant pain: a literature review.Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk?Perinatal maternal stress and serotonin signaling: effects on pain sensitivity in offspring.Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure.SSRIs in pregnancy--are they safe?Quality assessment of observational studies in psychiatry: an example from perinatal psychiatric research.Paroxetine use throughout pregnancy: does it pose any risk to the neonate?Chronic maternal fluoxetine infusion in pregnant sheep: effects on the maternal and fetal hypothalamic-pituitary-adrenal axes.Platelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors.Relation between prenatal maternal mood and anxiety and neonatal health.Maternal fluoxetine infusion does not alter fetal endocrine and biophysical circadian rhythms in pregnant sheep.Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.Prenatal influences on temperament development: The role of environmental epigenetics.Perinatal SSRI exposure permanently alters cerebral serotonin receptor mRNA in mice but does not impact adult behaviors.Sculpting infant soothability: the role of prenatal SSRI antidepressant exposure and neonatal SLC6A4 methylation status.Long-term consequences of neonatal fluoxetine exposure in adult rats.
P2860
Q26738460-DBA1236C-9EF3-4FF2-B808-95A62FAE8ED7Q27334448-B3FED066-B903-4BFB-9AE2-AF1D4AF36BCCQ30415540-AB973FD1-942B-47B9-9700-CE4A8E08C86DQ30479705-3F264D59-9F5C-45AC-B53D-3D69ED1378B5Q33940207-6C2F6CED-00E5-4F6D-918D-7467F4D34689Q34178991-F30E551C-D776-4651-9A18-32D8BA47DC28Q34255298-8F1771BC-AEF2-4EA5-8520-709A2BACB135Q34600630-28B451AD-95FA-403E-A2C5-8414EA311B0CQ34661348-E55671AF-461B-4061-86CD-AA84EAFA1D02Q35549316-EF50B1F2-9E6E-4D03-A261-B21F6AACE999Q35754818-A91C32A9-9151-4410-B905-3671389A3197Q35827404-3AF5E28E-4469-4BA0-9BF2-9D6ED91EA806Q36179728-23A5C778-FBBA-47FC-97CA-11A6E046B6AEQ36712871-C0C446F5-3B67-4477-A64D-1536DD7E2024Q36802999-D8733F31-19FB-4132-AFE8-76D7BADA137FQ36860205-12DE27E2-22B9-4434-8D89-9EFDD3927E3FQ37058701-BE4DB4ED-0EF0-4AD5-9415-203491403B8EQ37226375-1F16C86F-CC28-4B0E-94C9-A6FD96087B1BQ37337705-F454519C-275D-47EA-A923-96A7756A164AQ37643389-D056BF2B-662E-45E0-AC6F-BE3E865136C5Q37658594-64F0A0FF-D40A-4C1B-A6BC-668F682B910EQ37943435-BF8F9C99-DF33-43EF-BA41-971EE94EED46Q37975444-68791DA2-B15B-400B-AD3C-36B0C4C5FA8CQ38021727-CC3700D6-B23C-40D7-8872-ACD54F608868Q38169120-7768D01B-480F-4C15-9D94-10D068D3359CQ38215072-D26A9FE0-C35E-41F5-BFBB-D326AE00E8C0Q40535696-30D99FAC-717B-4FA2-8B20-87F0E1AC3E20Q42485832-B44DAFC2-7F39-48E4-994C-AF1ED320AE79Q43937277-572759AC-F76C-46B7-ABFE-E1A8951024DFQ44423190-65A7687E-E4F2-49AF-8EAD-DD007F6AA120Q44844284-E1F4F3B9-CFC9-444C-8F99-F4CA9DE7A8FEQ44885208-97E8E87F-12B1-4B8F-94A5-DCE1E212908CQ44969041-9E10B516-3879-4EA1-A8A4-F7A02F3D18DAQ45160312-2D7D56D2-46FE-477D-8CAE-DB7DDFFC824BQ46567654-F6F679D4-C501-4563-9359-E16DE990DC37Q46599065-BEAB08F4-0FE0-4D0B-9AAB-C4F729237DA4Q47578346-71E6E721-CA03-477C-B4CB-42F08E517BDEQ47801409-C2219C98-C900-4A27-A211-69AF9F1773D1Q48053531-2067A5E0-6711-49CA-B911-138927F8218FQ48305453-6DF864F6-BF5D-44D7-94B9-C760783E130C
P2860
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
@en
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
@nl
type
label
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
@en
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
@nl
prefLabel
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
@en
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.
@nl
P2093
P2860
P1433
P1476
Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response
@en
P2093
Ann-Louise Ellwood
Colleen Fitzgerald
Kenneth Wayne Riggs
Ruth Eckstein Grunau
Shaila Misri
P2860
P304
P356
10.1203/00006450-200204000-00008
P407
P577
2002-04-01T00:00:00Z
P5875
P6179
1041903096